Wirkstoffe & Arzneimittelsicherheit

Quellenpassagen (1)

Nebenwirkungen · Avonex

AVONEX 30 micrograms/0.5ml solution for injection in pre-filled pen. · Abschnitt 4.8 · PDF-Seite 22

*Class label for interferon beta products (see section 4.4). ┼ Class label for interferon products, see below Pulmonary arterial hypertension. 1 Injection site reactions including pain, inflammation and very rare cases of abscess or cellulitis that may require surgical intervention have been reported. 2 The frequency of occurrence is higher at the beginning of treatment. 3 A syncope episode may occur after AVONEX injection, it is normally a single episode that usually appears at the beginning of the treatment and does not recur with subsequent injections.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.

Vollständigen Kontext in der EMA-Fachinformation lesen →

Quellennachweis

Version 2026-05-26T09:52:00Z · SHA-256 8664cc1a15fbdec79adb60465103f20a92b713f43676504055a5ffd792417483 · Passage ad5264d322a1b8584b2adf29c3c373b079bd3a9bf88c538e6a2819d82c80a15d · Zeichen 7401–7969 im Abschnitt

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.